Publication:
Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors.

dc.contributor.authorCasanova-Acebes, Maria
dc.contributor.authorGrout, John A
dc.contributor.authorSirven, Philemon
dc.contributor.authorLeader, Andrew M
dc.contributor.authorMaskey, Shrisha
dc.contributor.authorHector, Eglantine
dc.contributor.authorPuisieux, Isabelle
dc.contributor.authorSteffan, Fiona
dc.contributor.authorCheng, Evan
dc.contributor.authorTung, Navpreet
dc.contributor.authorMaurin, Mathieu
dc.contributor.authorVaineau, Romain
dc.contributor.authorKarpf, Lea
dc.contributor.authorPlaud, Martin
dc.contributor.authorBegue, Anne-Laure
dc.contributor.authorGanesh, Koushik
dc.contributor.authorMesple, Jérémy
dc.contributor.authorCasanova-Acebes, Maria
dc.contributor.authorTabachnikova, Alexandra
dc.contributor.authorKeerthivasan, Shilpa
dc.contributor.authorLansky, Alona
dc.contributor.authorBerichel, Jessica Le
dc.contributor.authorWalker, Laura
dc.contributor.authorRahman, Adeeb H
dc.contributor.authorGnjatic, Sacha
dc.contributor.authorGirard, Nicolas
dc.contributor.authorLefevre, Marine
dc.contributor.authorDamotte, Diane
dc.contributor.authorAdam, Julien
dc.contributor.authorMartin, Jerome C
dc.contributor.authorWolf, Andrea
dc.contributor.authorFlores, Raja M
dc.contributor.authorBeasley, Mary Beth
dc.contributor.authorPradhan, Rachana
dc.contributor.authorMuller, Soren
dc.contributor.authorMarron, Thomas U
dc.contributor.authorTurley, Shannon J
dc.contributor.authorMerad, Miriam
dc.contributor.authorKenigsberg, Ephraim
dc.contributor.authorSalmon, Hélène
dc.contributor.funderRoche Holding Genentech
dc.contributor.funderFondation ARC pour la Recherche sur le Cancer
dc.contributor.funderScientific Computing at the Icahn School of Medicine at Mount Sinai
dc.date.accessioned2024-12-13T13:04:54Z
dc.date.available2024-12-13T13:04:54Z
dc.date.issued2022-11-02
dc.descriptionWe thank the important contributions of patients who participated in this study. This project was supported by Genentech, Inc. and carried out in collaboration with the Fondation ARC pour la recherche sur le cancer. The computational work was supported by the Scientific Computing at the Icahn School of Medicine at Mount Sinai and the Office of Research Infrastructure of the NIH under award number S10OD026880. This manuscript was edited at Life Science Editors, and the cartoon illustrations were created using BioRender.com . We thank the Mount Sinai Flow Cytometry Core, the Human Immune Monitoring Center, and the Biorepository and Pathology Core for their support. We thank Sarah Lagha, Anne-Sophie Tedesco, Agathe Seguin-Givelet, and Isabelle Sauret for their contribution to obtaining and studying additional FFPE NSCLC samples from Institut Mutualiste Montsouris. We thank Eliane Piaggio, Ana-Maria Lennon-Dumnil, and Olivier Lantz for carefully reading and commenting on the manuscript.
dc.description.abstractIt is currently accepted that cancer-associated fibroblasts (CAF) participate in T-cell exclusion from tumor nests. To unbiasedly test this, we used single-cell RNA sequencing coupled with multiplex imaging on a large cohort of lung tumors. We identified four main CAF populations, two of which are associated with T-cell exclusion: (i) MYH11+αSMA+ CAF, which are present in early-stage tumors and form a single cell layer lining cancer aggregates, and (ii) FAP+αSMA+ CAF, which appear in more advanced tumors and organize in patches within the stroma or in multiple layers around tumor nests. Both populations orchestrate a particular structural tissue organization through dense and aligned fiber deposition compared with T cell-permissive CAF. Yet they produce distinct matrix molecules, including collagen IV (MYH11+αSMA+ CAF) and collagen XI/XII (FAP+αSMA+ CAF). Hereby, we uncovered unique molecular programs of CAF driving T-cell marginalization, whose targeting should increase immunotherapy efficacy in patients bearing T cell-excluded tumors.
dc.description.abstractThe cellular and molecular programs driving T-cell marginalization in solid tumors remain unclear. Here, we describe two CAF populations associated with T-cell exclusion in human lung tumors. We demonstrate the importance of pairing molecular and spatial analysis of the tumor microenvironment, a prerequisite to developing new strategies targeting T cell-excluding CAF. See related commentary by Sherman, p. 2501. This article is highlighted in the In This Issue feature, p. 2483.
dc.description.peerreviewed
dc.format.number11
dc.format.page2606-2625
dc.format.volume12
dc.identifier.citationCancer Discov . 2022 Nov 2;12(11):2606-2625.
dc.identifier.pmchttps://pmc.ncbi.nlm.nih.gov/articles/PMC9633420/pdf/nihms-1834329.pdf
dc.identifier.pubmedID36027053
dc.identifier.urihttps://hdl.handle.net/20.500.12105/25878
dc.language.isoeng
dc.publisherAACR
dc.relation.publisherversionhttp://www.doi.org.10.1158/2159-8290.CD-21-1714
dc.repisalud.institucionCNIO
dc.repisalud.orgCNIO
dc.rights.accessRightsopen access
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectBASEMENT-MEMBRANES
dc.subjectSTROMAL CELLS
dc.subjectEARLY-PHASE IMAGEN
dc.subjectEXPRESSION
dc.subjectMIGRATION
dc.subjectINMUNITY
dc.subjectLYMPH
dc.subjectCITOKINE
dc.subjectANTIBODIE
dc.titleSpatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublication047b3088-9438-489e-9e86-15da17e2f4da

Files